Attenasio, Andrea
Kraeutler, Matthew J.
Hong, Ian S.
Baskar, Suriya
Patel, Deepak V.
Wright, Craig
Jankowski, Jaclyn M.
Liporace, Frank A.
Yoon, Richard S.
Article History
Received: 28 February 2023
Accepted: 9 March 2023
First Online: 22 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: Both RSY and FAL report no direct competing interests with the submitted work, however, other interests that might be perceived to influence the results and/or discussion reported in this paper have been disclosed below.
: American Association of Hip and Knee Surgeons: Board or committee member. Arthrex, Inc: IP royalties; Paid consultant. Bicomposites: Research support. Biomet: Research support. BuiltLean: Unpaid consultant. DePuy, A Johnson & Johnson Company: Paid consultant. Foundation for Physician Advancement: Board or committee member. Foundation of Orthopaedic Trauma: Board or committee member. Horizon Therapeutics: Paid presenter or speaker. LifeNet Health: Paid consultant; Research support. Organogenesis: Research support. OrthoGrid: Paid consultant. Orthopaedic Trauma Association: Board or committee member. ORTHOXEL: Paid consultant. SI-Bone: Paid consultant. Springer: Publishing royalties, financial or material support. Stryker: IP royalties; Paid consultant. Synthes: Paid consultant; Research support. Use-Lab: Paid consultant. WNT Scientific: Stock or stock Options.
: AAOS: Board or committee member. AO: Unpaid consultant. Biomet: IP royalties; Paid consultant; Paid presenter or speaker; Research support. DePuy, A Johnson & Johnson Company: IP royalties; Research support. Orthopaedic Trauma Association: Board or committee member. Stryker: IP royalties. Synthes: Paid consultant; Paid presenter or speaker.